Study for Late Assessment of the Safety and Efficacy of Biosimilar Rituximab
Clinical trial NCT04928573 · COMPLETED
Trial details
- NCT number
- NCT04928573
- Sponsor
- Libbs Farmacêutica LTDA
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-08
- Primary completion
- 2022-07-29
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.